The midbrain contains three populations of dopaminergic neurons. One group, in the substantia nigra (SN), projects to the dorsal striatum. These neurons are important for the control of movement and ...

Parkinson’s disease is a degenerative brain disease characterized by the loss of dopamine neurons in the midbrain-area called Substantia Nigra. The research group led by professor Mart Saarma, ...

In the lingo of the field, dopamine-producing cells are measuring a reward prediction error — the difference between the ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. 7 (Apr. 1, 2003), pp. 4245-4250 (6 pages) Dopaminergic (DA) neurons of substantia nigra in the midbrain ...

Parkinson's disease is characterized by the progressive loss of dopamine neurons in the substantia nigra of the midbrain. These neurons project widely throughout the cerebral hemispheres, but the ...

Researchers from Kumamoto University, Japan have found that a component derived from turmeric essential oil, aromatic turmerone (ar-turmerone), and its derivatives act directly on dopaminergic nerves ...

The neurotransmitter dopamine influences the activity of a wide variety of brain areas. A deficiency of this substance can have drastic consequences: The death of dopamine-producing nerve cells in the ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, with up to 10 million people affected worldwide. PD is characterized by progressive increase in movement disability and ...

Dopaminergic neurons in the mouse substantia nigra are replenished throughout the life of the animal, according to a report in the June 2 early online edition of PNAS. Moreover, the rate of ...

At the AD/PD meeting held last month in Vienna, scientists implicated T lymphocytes—specifically, the cytotoxic, CD8-positive variety—in Alzheimer’s disease. While the modus operandi of these cells in ...

BrainXell Therapeutics today announced the disclosure of its first scientific data, which will be presented at two conferences this month: the Cell Symposia | Gene and Cell-Based Therapies: Progress ...